Background pattern
DITROPAN 5 mg TABLETS

DITROPAN 5 mg TABLETS

Ask a doctor about a prescription for DITROPAN 5 mg TABLETS

5.0(17)
Doctor

Giorgi Eremeishvili

Urology22 years of experience

Giorgi Eremeishvili is a top-category urologist, a Candidate of Medical Sciences, and a licensed physician in Spain. He provides expert assistance in the diagnosis and treatment of a wide range of urological conditions in both men and women, employing a comprehensive approach and evidence-based principles.

Key areas of expertise:

  • Erectile dysfunction, decreased libido, premature ejaculation.
  • Male infertility: comprehensive diagnosis and modern treatment methods.
  • Prostate gland diseases: acute and chronic prostatitis, prostatic adenoma (benign prostatic hyperplasia), prostate cancer.
  • Inflammatory diseases of the genitourinary system: acute and chronic cystitis, pyelonephritis, epididymitis, orchitis, urethritis.
  • Sexually transmitted infections (STIs): chlamydia, ureaplasmosis, mycoplasmosis, gardnerellosis, candidiasis, herpetic infections, HPV, CMV, trichomoniasis, and others.
  • Urination disorders: urinary retention, frequent urination, urinary incontinence, overactive bladder, neurogenic bladder.
  • Neoplasms: cysts, tumors of the kidneys, bladder, testicles, prostate gland (including prostate cancer).
  • Surgical interventions: determining indications and selecting optimal minimally invasive methods.

Dr. Eremeishvili applies an integrated approach to each case. This includes thorough preoperative preparation, postoperative observation, and regular dynamic follow-up during the treatment process to achieve the best possible outcomes. All diagnostic and therapeutic recommendations are based on current evidence-based medicine and comply with the recommendations of the European Association of Urology, guaranteeing high-quality and effective care.

If you are seeking qualified assistance in diagnosing or treating urological conditions, book an online consultation with Dr. Giorgi Eremeishvili. Get expert support, accurate diagnosis, and a personalized treatment plan from the comfort of your home.

CameraBook a video appointment
€60
January 412:00
January 412:40
January 512:00
January 512:40
January 612:00
More times
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DITROPAN 5 mg TABLETS

Introduction

Package Leaflet: Information for the user

Ditropan5 mg tablets

oxybutynin hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is Ditropan and what is it used for
  2. What you need to know before you take Ditropan
  3. How to take Ditropan
  4. Possible side effects
  5. Storing Ditropan
  6. Contents of the pack and other information

1. What is Ditropan and what is it used for

Ditropan belongs to a group of medicines called urinary antispasmodics.

This medicine works on the contractions of the bladder and delays the need to urinate. It can be used to treat some types of incontinence and other urinary problems.

Ditropan can be used in children aged 5 years and older to treat:

  • involuntary loss of urine (urinary incontinence)
  • increased need or urgency to urinate
  • involuntary loss of urine at night, in combination with non-pharmacological treatment, when other treatments have not worked

2. What you need to know before you take Ditropan

Read the following sections carefully:

Do not take Ditropan

  • if you are allergic to oxybutynin hydrochloride or any of the other ingredients of this medicine (listed in section 6).
  • if you have any urinary tract disease with possible urinary retention.
  • if you have gastrointestinal disorders of an obstructive type, intestinal atony (laxity) or paralytic ileus (functional intestinal obstruction).
  • if you have toxic megacolon (abnormal constant dilation of the large intestine).
  • if you have severe ulcerative colitis (a disease that causes chronic diarrhea).
  • if you have myasthenia gravis (muscle weakness).
  • if you have glaucoma (increased eye pressure) or a shallow anterior chamber of the eye.
  • if you have increased urinary frequency and urinate more at night due to kidney or heart problems.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Ditropan.

Special care should be taken:

  • if you have Parkinson's disease because you have a higher risk of adverse reactions to the product.
  • if you have autonomic neuropathy (neurological disease).
  • if you have any intestinal disease (including intestinal obstruction), liver or kidney problems.
  • if you have clinically significant vesical obstruction, as it may worsen and cause urinary retention.
  • if you have gastrointestinal disorders, as Ditropan may decrease gastrointestinal motility.
  • if you have hiatal hernia/gastroesophageal reflux and/or are taking medications such as bisphosphonates, as they may cause or worsen esophagitis.
  • if you have a urinary tract infection, as appropriate antibacterial treatment should be instituted.
  • if you are taking other anticholinergic medications.
  • because Ditropan may worsen cognitive disorders, symptoms of prostatic hyperplasia (enlargement of the prostate) and tachycardia (increased heart rate). Therefore, it should be used with caution in cases of hyperthyroidism (overactive thyroid gland), congestive heart failure, cardiac arrhythmia (heart rhythm disorders), coronary artery disease, and hypertension (high blood pressure).
  • because Ditropan may produce anticholinergic effects on the nervous system, e.g., hallucinations, agitation, sleep disorders, confusion, blurred vision, and somnolence, and alcohol consumption may also increase somnolence.
  • because Ditropan may cause angle-closure glaucoma. If you experience sudden loss of visual acuity or eye pain, contact a doctor immediately.
  • because Ditropan may reduce saliva production, leading to the formation of dental caries, gum inflammation, or fungal infections in the mouth.
  • if you are in a place with very high temperatures or have a fever, you may feel heat exhaustion due to decreased sweating caused by this medication.

Elderly patients

Ditropan should be used with caution in elderly patients because they have a higher risk of experiencing adverse reactions and due to the risk of cognitive decline.

Children

Children under 5 years of age

The use of this medication is not recommended in children under 5 years of age.

Children aged 5 years and older

Children in this age group have a higher risk of experiencing adverse reactions to the product.

Other medicines and Ditropan

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.

Ditropan may affect the absorption of concomitantly administered medications.

Especially, inform your doctor if you are currently taking any of the following medications:

  • phenothiazines, butyrophenones, clozapine (used in mental illnesses)
  • medications used to treat dementia, e.g., donepezil, rivastigmine, galantamine, or tacrine (cholinesterase inhibitors)
  • tricyclic antidepressants (used to treat depression)
  • antihistamines (used to treat allergies)
  • amantadine, biperiden, levodopa (used for Parkinson's disease)
  • quinidine (used to treat heart problems)
  • certain medications used for fungal infections (e.g., ketoconazole and fluconazole) or certain antibiotics such as erythromycin
  • atropine and related compounds (used to prevent muscle contractions)
  • other anticholinergic medications
  • dipyridamole (used to prevent thrombus formation)
  • prokinetics (used to increase digestive tract movements)
  • bisphosphonates (used to treat osteoporosis)
  • digitalis (used to stimulate the heart)

Ditropan with alcohol

The simultaneous use of Ditropan and alcohol may increase somnolence.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Pregnancy

If you are pregnant or suspect you may be pregnant while taking Ditropan, you must inform your doctor immediately. It is recommended not to take this medicine during pregnancy, unless your doctor considers it necessary.

Breastfeeding

Ditropan passes into breast milk. The use of this medicine is not recommended during breastfeeding. If your doctor considers it necessary, breastfeeding will be interrupted.

Driving and using machines

Ditropan causes somnolence or blurred vision, so you should be careful when performing activities that require a state of mental alertness, such as driving, operating machinery, or performing hazardous work while using this medicine.

Abuse and dependence

Dependence on oxybutynin has been observed in patients with a history of substance abuse or dependence (see section 4).

Ditropan contains lactose

This medicine contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.

Ditropan contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per unit dose; it is essentially "sodium-free".

3. How to take Ditropan

Follow the administration instructions of this medicine exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

Dosage

Adults

The recommended dose in adults is 3 tablets (15 mg of oxybutynin hydrochloride) per day, divided into three doses, although they can also be taken together at the end of the day in case of nocturnal urinary problems. The dose can be increased to 4 tablets (20 mg of oxybutynin hydrochloride) per day and also reduced to a lower maintenance dose.

Use in children and adolescents

Children under 5 years of age

The safety and efficacy of Ditropan have not been established in children under 5 years of age.

Children aged 5 years and older

A dose of 2 tablets (10 mg of oxybutynin hydrochloride) per day is recommended. There should be at least 4 hours between each dose.

Elderly patients

In elderly patients, a dose of 2 tablets per day is usually sufficient.

If you think the effect of Ditropan is too strong or too weak, consult your doctor or pharmacist.

Method of administration

Remember to take your medicine. Ditropan should be taken regularly according to your doctor's instructions throughout the treatment.

Ditropan is indicated for oral use only.

The tablet should be swallowed whole or can be broken and taken with a large amount of liquid to ensure passage through the esophagus. The taste of the tablets is not pleasant.

If you take more Ditropan than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.

If you have taken too much Ditropan, you may experience some symptoms, e.g., restlessness, excitement, psychotic behavior, flushing, decreased blood pressure, respiratory problems, paralysis, and coma.

If you forget to take Ditropan

In case of forgetting a dose, wait for the next one. Do not take a double dose to make up for the forgotten doses.

If you stop taking Ditropan

If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Very common side effects (may affect more than 1 in 10 people):

Dry mouth, constipation, nausea, dizziness, somnolence, blurred vision, difficulty urinating, dry skin, headache.

Common side effects (may affect up to 1 in 10 people):

Asthenia, diarrhea, vomiting, dysgeusia (disorder of taste), flatulence (gas), confusion, atrial arrhythmia, nodal arrhythmia, supraventricular extrasystole, strong heartbeats that can be rapid or irregular, dry eyes, urinary retention, hematuria (blood in the urine), nocturia (need to urinate at night), pyuria (presence of leukocytes in the urine), pharyngitis (inflammation of the pharynx), skin redness.

Uncommon side effects (may affect up to 1 in 100 people):

Abdominal discomfort, anorexia (loss of appetite), decreased appetite, dysphagia (difficulty swallowing), cough, epistaxis (nasal bleeding), vulvovaginitis (inflammation of the vulva and vagina).

Rare side effects (may affect up to 1 in 1,000 people):

Photosensitivity (sensitivity to light), thrombocytopenia (reduction in platelet count).

Frequency not known (cannot be estimated from the available data):

Gastroesophageal reflux, gastritis, pseudo-obstruction in at-risk patients (in elderly patients or patients with constipation and being treated with other medications that decrease intestinal motility), hallucinations, agitation, convulsions, anxiety, nightmares, paranoia (distrust, delusions), cognitive disorders, especially in elderly patients, symptoms of depression, and dependence on oxybutynin (in patients with a history of substance abuse or dependence), tachycardia (increased heart rate), arrhythmia, angle-closure glaucoma (increased intraocular pressure), mydriasis (pupil dilation), intraocular hypertension, urinary tract infection, adverse reactions such as generalized cutaneous erythema, urticaria, angioedema (generalized inflammation of feet, hands, throat, lips, and respiratory tract), skin rash, hypohidrosis (decreased sweat production), heat stroke, hypersensitivity, muscular disorders (pain, cramps, or weakness).

Reporting of side effects

If you experience any side effects, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storing Ditropan

Keep this medicine out of the sight and reach of children.

Store in the original package. Store below 30 °C.

Do not use this medicine after the expiration date stated on the package after EXP. The expiration date is the last day of the month indicated.

Do not use this medicine if you notice that the tablets have a different appearance (e.g., if they change color).

Medicines should not be disposed of via wastewater or household waste. Return the packages and medicines you no longer need to the SIGRE collection point at the pharmacy. Ask your pharmacist how to dispose of packages and medicines you no longer need. This will help protect the environment.

6. Contents of the pack and other information

Composition of Ditropan

  • The active ingredient is oxybutynin hydrochloride. Each tablet contains 5 mg of oxybutynin hydrochloride.
  • The other ingredients (excipients) are: lactose, aluminum lake indigo (E132), microcrystalline cellulose, and calcium stearate.

Appearance of the product and contents of the pack

Ditropan is presented in the form of tablets. Each package contains 60 tablets. The tablets are round, biconvex, light blue in color with a central score line on one face and the engraving "OXB5" on the opposite face.

Marketing authorization holder and manufacturer

Marketing authorization holder

CHEPLAPHARM Arzneimittel GmbH

Ziegelhof 24

17489 Greifswald

Germany

Manufacturer

Sanofi Winthrop Industrie

Avenue Gustave Eiffel, 30-36

37100 Tours

France

or

Fidelio Healthcare Limburg GmbH

Mundipharmastraße 2

65549 Limburg an der Lahn

Germany

Local representative

Laboratorios Rubió, S.A.

Industria, 29

Pol. Ind. Comte de Sert

08755 Castellbisbal (Barcelona)

Spain

Date of the last revision of this leaflet: June 2023.

Other sources of information

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

About the medicine

How much does DITROPAN 5 mg TABLETS cost in Spain ( 2026)?

The average price of DITROPAN 5 mg TABLETS in January, 2026 is around 4.15 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.

Alternatives to DITROPAN 5 mg TABLETS in other countries

The best alternatives with the same active ingredient and therapeutic effect.

Alternative to DITROPAN 5 mg TABLETS in Poland

Dosage form: Tablets, 5 mg
Active substance: oxybutynin
Marketing authorisation holder (MAH): Cheplapharm Arzneimittel GmbH
Prescription required
Dosage form: Tablets, 5 mg
Active substance: oxybutynin
Marketing authorisation holder (MAH): Cheplapharm Arzneimittel GmbH
Prescription required
Dosage form: Tablets, 5 mg
Active substance: oxybutynin
Marketing authorisation holder (MAH): Cheplapharm Arzneimittel GmbH
Prescription required
Dosage form: Tablets, 5 mg
Active substance: oxybutynin
Marketing authorisation holder (MAH): Cheplapharm Arzneimittel GmbH
Prescription required
Dosage form: Tablets, 5 mg
Active substance: oxybutynin
Marketing authorisation holder (MAH): Cheplapharm Arzneimittel GmbH
Prescription required
Dosage form: Solution, 1 mg/ml
Active substance: oxybutynin
Prescription required

Alternative to DITROPAN 5 mg TABLETS in Ukraine

Dosage form: tablets, tablets 5mg
Active substance: oxybutynin
Prescription required
Dosage form: tablets, tablets 5mg
Active substance: oxybutynin
Manufacturer: Astrea Fonten
Prescription required

Online doctors for DITROPAN 5 mg TABLETS

Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DITROPAN 5 mg TABLETS – subject to medical assessment and local rules.

5.0(8)
Doctor

Iryna Reznychenko

Gynecology26 years of experience

Dr Iryna Reznychenko is an obstetrician-gynaecologist, paediatric gynaecologist, and certified lactation consultant. She provides online consultations for women at all stages of life – from adolescence to menopause. Her work combines medical care for gynaecological conditions with dedicated support for breastfeeding challenges, both physical and emotional.

Areas of expertise:

  • interpretation of test results and personalised treatment planning
  • menstrual irregularities, PCOS, endometriosis
  • abnormal uterine bleeding, endometrial hyperplasia, cervical dysplasia
  • care during perimenopause and menopause, hormonal balance, cancer prevention
  • breastfeeding issues: nipple pain, cracked skin, blocked ducts, low milk supply
  • support during the postpartum and lactation period
Dr Reznychenko offers a clear, attentive and professional approach. Her consultations help prevent minor discomforts from developing into more serious concerns – all in a convenient online format.
CameraBook a video appointment
€50
January 307:00
January 307:50
January 308:40
January 309:30
January 310:20
More times
5.0(17)
Doctor

Giorgi Eremeishvili

Urology22 years of experience

Giorgi Eremeishvili is a top-category urologist, a Candidate of Medical Sciences, and a licensed physician in Spain. He provides expert assistance in the diagnosis and treatment of a wide range of urological conditions in both men and women, employing a comprehensive approach and evidence-based principles.

Key areas of expertise:

  • Erectile dysfunction, decreased libido, premature ejaculation.
  • Male infertility: comprehensive diagnosis and modern treatment methods.
  • Prostate gland diseases: acute and chronic prostatitis, prostatic adenoma (benign prostatic hyperplasia), prostate cancer.
  • Inflammatory diseases of the genitourinary system: acute and chronic cystitis, pyelonephritis, epididymitis, orchitis, urethritis.
  • Sexually transmitted infections (STIs): chlamydia, ureaplasmosis, mycoplasmosis, gardnerellosis, candidiasis, herpetic infections, HPV, CMV, trichomoniasis, and others.
  • Urination disorders: urinary retention, frequent urination, urinary incontinence, overactive bladder, neurogenic bladder.
  • Neoplasms: cysts, tumors of the kidneys, bladder, testicles, prostate gland (including prostate cancer).
  • Surgical interventions: determining indications and selecting optimal minimally invasive methods.

Dr. Eremeishvili applies an integrated approach to each case. This includes thorough preoperative preparation, postoperative observation, and regular dynamic follow-up during the treatment process to achieve the best possible outcomes. All diagnostic and therapeutic recommendations are based on current evidence-based medicine and comply with the recommendations of the European Association of Urology, guaranteeing high-quality and effective care.

If you are seeking qualified assistance in diagnosing or treating urological conditions, book an online consultation with Dr. Giorgi Eremeishvili. Get expert support, accurate diagnosis, and a personalized treatment plan from the comfort of your home.

CameraBook a video appointment
€60
January 412:00
January 412:40
January 512:00
January 512:40
January 612:00
More times

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2026 Oladoctor. All rights reserved.
VisaMastercardStripe